{"id":"https://openalex.org/W2139734588","doi":"https://doi.org/10.1046/j.0306-5251.2001.01409.x","title":"The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV\u20101\u2010infected individuals","display_name":"The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV\u20101\u2010infected individuals","publication_year":2001,"publication_date":"2001-06-01","ids":{"openalex":"https://openalex.org/W2139734588","doi":"https://doi.org/10.1046/j.0306-5251.2001.01409.x","mag":"2139734588","pmid":"https://pubmed.ncbi.nlm.nih.gov/11422025","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2014488"},"language":"en","primary_location":{"id":"doi:10.1046/j.0306-5251.2001.01409.x","doi":"https://doi.org/10.1046/j.0306-5251.2001.01409.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.0306-5251.2001.01409.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.0306-5251.2001.01409.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.0306-5251.2001.01409.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113785658","display_name":"Cornelis H.W. Koks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"C. H. W. Koks","raw_affiliation_strings":["Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands. Apkko@slz.nl","Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands. Apkko@slz.nl","institution_ids":["https://openalex.org/I2802065108"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034884716","display_name":"Kristel M. L. Crommentuyn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"K. M. L. Crommentuyn","raw_affiliation_strings":["Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030426323","display_name":"Richard M. W. Hoetelmans","orcid":"https://orcid.org/0000-0001-5582-3627","observed_orcids":["https://orcid.org/0000-0001-5582-3627"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"R. M. W. Hoetelmans","raw_affiliation_strings":["Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103360080","display_name":"D.M. Burger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"D. M. Burger","raw_affiliation_strings":["Department of Clinical Pharmacy, Nijmegen University Hospital, Nijmegen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, Nijmegen University Hospital, Nijmegen,","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109180691","display_name":"P.P. Koopmans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. P. Koopmans","raw_affiliation_strings":["Department of Internal Medicine, Nijmegen University Hospital, Nijmegen and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Nijmegen University Hospital, Nijmegen and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021986417","display_name":"Ron A. A. Math\u00f4t","orcid":"https://orcid.org/0000-0001-8401-0879","observed_orcids":["https://orcid.org/0000-0001-8401-0879"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"R. A. A. Math\u00f4t","raw_affiliation_strings":["Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102945216","display_name":"Jan Willem Mulder","orcid":"https://orcid.org/0000-0002-9768-3797","observed_orcids":["https://orcid.org/0000-0002-9768-3797"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. W. Mulder","raw_affiliation_strings":["Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109900774","display_name":"P. L. Meenhorst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"P. L. Meenhorst","raw_affiliation_strings":["Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. H. Beijnen","raw_affiliation_strings":["Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,","institution_ids":["https://openalex.org/I2802065108"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113785658"],"corresponding_institution_ids":["https://openalex.org/I2802065108"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.2275,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.79894106,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"51","issue":"6","first_page":"631","last_page":"635"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.03009999915957451,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":1.0},{"id":"https://openalex.org/keywords/ritonavir","display_name":"ritonavir","score":0.9909999966621399},{"id":"https://openalex.org/keywords/saquinavir","display_name":"saquinavir","score":1.0},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.9259999990463257},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7630000114440918},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.949999988079071},{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.765999972820282},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.5270000100135803}],"concepts":[{"id":"https://openalex.org/C2776937687","wikidata":"https://www.wikidata.org/wiki/Q422654","display_name":"Saquinavir","level":5,"score":0.9833575487136841},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.9503050446510315},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8141485452651978},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.6434148550033569},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6179794669151306},{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.5196665525436401},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46541452407836914},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.26763448119163513},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.21039673686027527},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.19196078181266785},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.15424981713294983},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.07589364051818848},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019258","descriptor_name":"Saquinavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019258","descriptor_name":"Saquinavir","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019258","descriptor_name":"Saquinavir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1046/j.0306-5251.2001.01409.x","doi":"https://doi.org/10.1046/j.0306-5251.2001.01409.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.0306-5251.2001.01409.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.0306-5251.2001.01409.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2014488","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2014488","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:11422025","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11422025","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Clinical Trial"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/84efa90a-3302-4ab1-b3fb-94da2eb41cc9","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/the-effect-of-fluconazole-on-ritonavir-and-saquinavir-pharmacokinetics-in-hiv1infected-individuals(84efa90a-3302-4ab1-b3fb-94da2eb41cc9).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British journal of clinical pharmacology, 51(6), 631 - 635. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/d7b58aad-1dbd-4b07-88cd-a489a9546aa3","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/d7b58aad-1dbd-4b07-88cd-a489a9546aa3","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Koks, C H, Crommentuyn, K M, Hoetelmans, R M, Burger, D M, Koopmans, P P, Math\u00f4t, R A, Mulder, J W, Meenhorst, P L & Beijnen, J H 2001, 'The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals', British journal of clinical pharmacology, vol. 51, no. 6, pp. 631-635. https://doi.org/10.1046/j.0306-5251.2001.01409.x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/160329","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/160329","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Clinical Pharmacology, 51, 6, pp. 631--5","raw_type":"Article / Letter to editor"},{"id":"pmh:ru:oai:repository.ubn.ru.nl:2066/160329","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/160329","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Clinical Pharmacology, 51, 631- - 5","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1046/j.0306-5251.2001.01409.x","doi":"https://doi.org/10.1046/j.0306-5251.2001.01409.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.0306-5251.2001.01409.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.0306-5251.2001.01409.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2139734588.pdf"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1581407744","https://openalex.org/W1979855339","https://openalex.org/W1986185948","https://openalex.org/W2007879783","https://openalex.org/W2012066169","https://openalex.org/W2025491601","https://openalex.org/W2042312816","https://openalex.org/W2043431710","https://openalex.org/W2055539353","https://openalex.org/W2064712711","https://openalex.org/W2068946470","https://openalex.org/W2077898677","https://openalex.org/W2088787526","https://openalex.org/W2107877434","https://openalex.org/W2110100735","https://openalex.org/W2130099592","https://openalex.org/W2139578839","https://openalex.org/W2329313939","https://openalex.org/W2414555537","https://openalex.org/W4251307042"],"related_works":["https://openalex.org/W2130099592","https://openalex.org/W2108524243","https://openalex.org/W2016523223","https://openalex.org/W2160539237","https://openalex.org/W7098290661","https://openalex.org/W2146848920","https://openalex.org/W1987138081","https://openalex.org/W2075257594","https://openalex.org/W2090474536","https://openalex.org/W2133274889"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"study":[2],"the":[3,8,12,32,51,83,86,90,93,128,156,165,175,194],"effect":[4],"of":[5,11,170,174,179,190],"fluconazole":[6,58],"on":[7,47,61,67,76,168],"steady-state":[9],"pharmacokinetics":[10],"protease":[13,33,53],"inhibitors":[14],"ritonavir":[15,30,42,157],"and":[16,27,50,64,79,121,125,149],"saquinavir":[17,26,84],"in":[18,55,89,131,164],"HIV-1-infected":[19],"patients.":[20],"METHODS:":[21],"Five":[22],"subjects":[23],"treated":[24],"with":[25,29,57,187],"three":[28,39],"received":[31],"inhibitor":[34,54],"alone":[35],"(saquinavir":[36],"1200":[37],"mg":[38,44,60,66],"times":[40],"daily,":[41],"600":[43],"twice":[45],"daily)":[46],"day":[48,62],"1,":[49],"same":[52],"combination":[56],"(400":[59],"2":[63],"200":[65],"days":[68,77],"3":[69],"to":[70,106,135],"8).":[71],"Pharmacokinetic":[72],"parameters":[73,167],"were":[74,160],"determined":[75],"1":[78],"8.":[80],"RESULTS:":[81],"In":[82,155],"group,":[85,158],"median":[87,114,142],"increase":[88],"area":[91],"under":[92],"plasma":[94,132],"concentration":[95,130],"vs":[96],"time":[97],"curve":[98],"was":[99],"50%":[100],"from":[101],"1800":[102],"microg":[103,108,117,137,145,153],"l(-1)":[104,109,118,146],"h":[105,110],"2700":[107],"(P":[111],"=":[112,140],"0.04,":[113],"increase:":[115,143],"900":[116],"h;":[119],"2.5":[120,148],"97.5":[122,150],"percentile:":[123,151],"500-1300),":[124],"56%":[126],"for":[127,196],"peak":[129],"(from":[133],"550":[134],"870":[136],"l(-1),":[138],"P":[139],"0.04;":[141],"320":[144],"h,":[147],"60-450":[152],"l(-1)).":[154],"there":[159],"no":[161],"detectable":[162],"changes":[163],"pharmacokinetic":[166],"addition":[169],"fluconazole.":[171],"CONCLUSIONS:":[172],"Because":[173],"favourable":[176],"safety":[177],"profile":[178],"saquinavir,":[180],"dose":[181],"adjustments":[182],"are":[183],"probably":[184],"not":[185],"necessary":[186],"concomitant":[188],"use":[189],"fluconazole,":[191],"as":[192],"is":[193],"case":[195],"ritonavir.":[197]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}